These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E. Song YS; Park YJ Endocrinol Metab (Seoul); 2020 Sep; 35(3):515-525. PubMed ID: 32981294 [TBL] [Abstract][Full Text] [Related]
83. Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review. McKelvey BA; Umbricht CB; Zeiger MA Front Endocrinol (Lausanne); 2020; 11():485. PubMed ID: 32849278 [No Abstract] [Full Text] [Related]
84. Mutations of the Liu R; Li Y; Chen W; Cong J; Zhang Z; Ma L; Chu L; Xiao H; Zhang Y; Liu Y; Xu Y; Yu Q; Yang X; Sun C Oncol Lett; 2020 Oct; 20(4):50. PubMed ID: 32802170 [TBL] [Abstract][Full Text] [Related]
85. Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma. Póvoa AA; Teixeira E; Bella-Cueto MR; Melo M; Oliveira MJ; Sobrinho-Simões M; Maciel J; Soares P Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138175 [TBL] [Abstract][Full Text] [Related]
86. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer. Dionísio de Sousa IJ; Marques DS; Príncipe C; Portugal RV; Canberk S; Prazeres H; Lopes JM; Gimba ERP; Lima RT; Soares P Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32731632 [TBL] [Abstract][Full Text] [Related]
88. SLC26A9 promotes colorectal tumorigenesis by modulating Wnt/β-catenin signaling. Zhang M; Ma Z; Yi Z; Wang H; Zhu J; Wen G; Jin H; An J; Deng Z; Tuo B; Li T; Liu X Cell Death Discov; 2024 Mar; 10(1):123. PubMed ID: 38461207 [TBL] [Abstract][Full Text] [Related]
89. Significance of Furin Expression in Thyroid Neoplastic Transformation. Azevedo MT; Macedo S; Canberk S; Cardoso L; Gaspar TB; Pestana A; Batista R; Sobrinho-Simões M; Soares P Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568724 [No Abstract] [Full Text] [Related]
90. An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review). Karaviti E; Kontogiannis A; Anastopoulos A; Kotteas E; Gomatou G Mol Clin Oncol; 2023 Aug; 19(2):61. PubMed ID: 37424625 [TBL] [Abstract][Full Text] [Related]
92. Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance. Yuan X; Yuan H; Zhang N; Liu T; Xu D Clin Transl Med; 2022 Nov; 12(11):e1111. PubMed ID: 36394204 [TBL] [Abstract][Full Text] [Related]
93. Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers. Montero-Conde C; Leandro-García LJ; Martínez-Montes ÁM; Martínez P; Moya FJ; Letón R; Gil E; Martínez-Puente N; Guadalix S; Currás-Freixes M; García-Tobar L; Zafon C; Jordà M; Riesco-Eizaguirre G; González-García P; Monteagudo M; Torres-Pérez R; Mancikova V; Ruiz-Llorente S; Pérez-Martínez M; Pita G; Galofré JC; Gonzalez-Neira A; Cascón A; Rodríguez-Antona C; Megías D; Blasco MA; Caleiras E; Rodríguez-Perales S; Robledo M Clin Transl Med; 2022 Aug; 12(8):e1001. PubMed ID: 35979662 [TBL] [Abstract][Full Text] [Related]
94. Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis. Gan XX; Li YY; Li SJ; Mo SS; Feng JH; Shen F; Cai WS; Lai YQ; Xu B Front Oncol; 2021; 11():680873. PubMed ID: 34422633 [TBL] [Abstract][Full Text] [Related]